Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-04

FDA Approved: BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE — Original Application (Dr. Reddy's Labratories Inc.)

View source ↗

Summary

FDA approved an original ANDA for a generic cough-and-cold medication containing brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide (brompheniramine maleate; pseudoephedrine hydrochloride; dextromethorphan hydrobromide)

Snippet

ORIG AP for BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE (BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE)